Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 4, 2006

Center for Human Genetics’ Autism Study Will Use Illumina Technology

  • Duke University’s Center for Human Genetics (CHG) selected the Illumina’s Infinium HumanHap550 BeadChip for an Autism study of over 1,800 individuals and their families. CHG hopes that the identification of the genes that contribute to a complex disease like autism will lead to the development of enhanced diagnostic tools, early detection, and improved health outcomes for patients and their families.

    “Multiple genes and the interactions of these genes contribute to diseases like autism, making their identification very difficult,” notes Margaret Pericak-Vance, Ph.D., who along with John R. Gilbert will lead the research. “New technologies and creative thinking are required for the advancement of these projects.”



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »